Please note that the recruitment of patients to VIABLE clinical trial was successfully completed.


View the Map

Participating Medical Centers

You have entered website for VIABLE study – phase III global clinical trial for prostate cancer treatment (DCVAC/PCa). This clinical trial is intended for patients with metastatic castration- resistant prostate cancer, who meet the entry criteria and consent to participate.

Only a physician conducting a clinical evaluation of an investigational treatment DCVAC/PCa can decide whether or not a patient can be included in a clinical trial. This is based on the criteria defined in the study protocol which is approved by the health care authorities.

The term “investigational treatment” means that it has not yet been approved by the European Medicines Agency (EMA) or Food and Drug Administration (FDA) for the treatment of prostate cancer.

You can find the participating medical centres listed below.


Participating Medical Center Address Principal investigator Phone  
Klaipėdos Universitetinė ligoninė, Onkologijos ir Chemoterapijos skyrius
Liepojos g. 41,
LT-92288 Klaipėda
Gyd. Alvydas Česas +370 687 13855 E-mail
Nacionalinis Vėžio centras, Poliklinika, Chemoterapijos skyrius
Santariškių g. 1,
LT-08660 Vilnius
Gyd. Jolita Asadauskienė +370 684 36346 E-mail
Vilniaus Universiteto ligoninės, Santariškių klinikos, Onkologijos chemoterapijos skyrius
Santariškių g. 2,
LT-08661 Vilnius
Gyd. Skaistė Tulytė +370 614 80726 E-mail